LABU vs. XTJL
LABU (Direxion Daily S&P Biotech Bull 3x Shares) and XTJL (Innovator U.S. Equity Accelerated Plus ETF - July) are both Leveraged Equities funds. LABU is passively managed, while XTJL is actively managed. Over the past 3 years, LABU returned 7.82%/yr vs 14.68%/yr for XTJL. A 0.54 correlation means they provide meaningful diversification when combined. LABU charges 1.12%/yr vs 0.79%/yr for XTJL.
Performance
LABU vs. XTJL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABU achieves a 3.80% return, which is significantly lower than XTJL's 5.36% return.
LABU
- 1D
- 4.61%
- 1M
- -11.09%
- YTD
- 3.80%
- 6M
- 3.63%
- 1Y
- 195.85%
- 3Y*
- 7.82%
- 5Y*
- -32.76%
- 10Y*
- -13.53%
XTJL
- 1D
- 0.00%
- 1M
- 1.16%
- YTD
- 5.36%
- 6M
- 6.38%
- 1Y
- 15.64%
- 3Y*
- 14.68%
- 5Y*
- —
- 10Y*
- —
LABU vs. XTJL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 3.80% | 79.17% | -26.02% | -13.41% | -80.36% | -54.11% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 5.36% | 15.42% | 14.43% | 25.72% | -15.66% | 7.28% |
Correlation
The correlation between LABU and XTJL is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (All Time) Calculated using the full available price history since Jul 2, 2021 | 0.54 |
The correlation between LABU and XTJL has been stable across timeframes, ranging from 0.46 to 0.54 - a consistent structural relationship.
LABU vs. XTJL - Sectors Allocation Comparison
Sectors
LABU
XTJL
Healthcare
Financial Services
Basic Materials
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
LABU
XTJL
Financial Services
LABU
XTJL
Basic Materials
LABU
XTJL
Communication Services
LABU
-
XTJL
Consumer Cyclical
LABU
-
XTJL
Consumer Defensive
LABU
-
XTJL
Energy
LABU
-
XTJL
Industrials
LABU
-
XTJL
Real Estate
LABU
-
XTJL
Technology
LABU
-
XTJL
Utilities
LABU
-
XTJL
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABU vs. XTJL — Risk / Return Rank
LABU
XTJL
LABU vs. XTJL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABU | XTJL | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.60 | 2.12 | +0.48 |
Sortino ratioReturn per unit of downside risk | 2.93 | 3.14 | -0.21 |
Omega ratioGain probability vs. loss probability | 1.35 | 1.46 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | 6.42 | 3.07 | +3.35 |
Martin ratioReturn relative to average drawdown | 18.77 | 17.37 | +1.40 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LABU | XTJL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.60 | 2.12 | +0.48 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.34 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.14 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.24 | 0.65 | -0.88 |
Drawdowns
LABU vs. XTJL - Drawdown Comparison
The maximum LABU drawdown since its inception was -99.18%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for LABU and XTJL.
Loading charts...
Drawdown Indicators
| LABU | XTJL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.18% | -23.24% | -75.94% |
Max Drawdown (1Y)Largest decline over 1 year | -30.70% | -5.12% | -25.58% |
Max Drawdown (3Y)Largest decline over 3 years | -78.30% | -16.70% | -61.60% |
Max Drawdown (5Y)Largest decline over 5 years | -97.59% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -98.96% | — | — |
Current DrawdownCurrent decline from peak | -96.34% | 0.00% | -96.34% |
Average DrawdownAverage peak-to-trough decline | -81.68% | -4.04% | -77.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.48% | 0.90% | +9.58% |
Volatility
LABU vs. XTJL - Volatility Comparison
Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 27.83% compared to Innovator U.S. Equity Accelerated Plus ETF - July (XTJL) at 0.33%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than XTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABU | XTJL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.83% | 0.33% | +27.50% |
Volatility (6M)Calculated over the trailing 6-month period | 59.70% | 5.72% | +53.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.91% | 7.43% | +68.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 95.58% | 15.22% | +80.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.42% | 15.22% | +80.20% |
LABU vs. XTJL - Expense Ratio Comparison
LABU has a 1.12% expense ratio, which is higher than XTJL's 0.79% expense ratio.
Dividends
LABU vs. XTJL - Dividend Comparison
LABU's dividend yield for the trailing twelve months is around 0.74%, while XTJL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.74% | 0.84% | 0.35% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
LABU and XTJL have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABU has higher volatility (27.83%) compared to XTJL (0.33%). In terms of maximum drawdown, LABU dropped -99.18% vs XTJL's -23.24%.
On 3-year performance, XTJL leads with 14.68% vs 7.82% for LABU. On fees, XTJL is cheaper at 0.79% per year. On volatility, XTJL has been the lower-risk option at 0.33%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, XTJL has performed better with a 14.68% return vs 7.82%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XTJL is cheaper with a 0.79% expense ratio, compared with 1.12% for LABU.
LABU has the higher dividend yield at 0.74%, compared with 0.00% for XTJL.
They also come from different issuers: Direxion and Innovator. Their fees differ too: 1.12% for LABU and 0.79% for XTJL.
LABU currently has the higher Sharpe Ratio (2.60 vs 2.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABU and XTJL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer